WeVote
Log In

Bill

NS

Bill

SCR 19

Expresses support for TrumpRx and the GENEROUS Model

2026 Regular Session Introduced by Nick Schroer

Missouri legislature expresses support for TrumpRx and GENEROUS Model prescription drug cost reduction initiatives through non-binding concurrent resolution.

0
WeVote Research Nonpartisan
Bill Summary · SCR 19

Legislative bill overview

SCR 19 is a concurrent resolution expressing legislative support for "TrumpRx" and the "GENEROUS Model," initiatives focused on reducing prescription drug costs. As a concurrent resolution rather than statutory legislation, it does not create binding law but serves as a formal statement of the Missouri legislature's position on these drug pricing approaches.

Why is this important

Prescription drug costs represent a significant burden for many Americans and Missourians. Legislative resolutions can influence state policy direction, attract federal attention, and signal public support for particular drug pricing strategies, potentially shaping future regulatory and legislative efforts in Missouri and beyond.

Potential points of contention

  • Lack of specificity: The resolution does not define detailed mechanisms of "TrumpRx" or the "GENEROUS Model," making it unclear what specific policies are being endorsed
  • Partisan framing: The naming convention may suggest alignment with a particular political figure or administration, which could generate debate about whether drug pricing reform should be framed through partisan versus bipartisan approaches
  • Implementation questions: Concurrent resolutions express support but don't establish how these models would be implemented, funded, or enforced in Missouri's healthcare system

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.